DJ Vertex Pharmaceuticals Inc. Stock Underperforms Thursday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Vertex Pharmaceuticals Inc. $(VRTX)$ shed 1.77% to $516.44 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 0.65% to 7,798.99 and the Dow Jones Industrial Average rising 0.13% to 53,839.99.
This was the stock's second consecutive day of losses.
Vertex Pharmaceuticals Inc. closed 5.44% below its 52-week high of $546.17, which the company reached on August 10th.
The stock underperformed when compared to some of its competitors Thursday, as AbbVie Inc. $(ABBV)$ rose 0.83% to $250.82, Krystal Biotech Inc. (KRYS) fell 1.36% to $328.34, and Arcturus Therapeutics Holdings Inc. $(ARCT)$ rose 3.42% to $7.86.
Trading volume (862,044) remained 763,073 below its 50-day average volume of 1.6 M.
Data source: Dow Jones Market Data, FactSet. Data compiled August 13, 2026.